<p>NORCROSS, Ga., Sept. 26, 2023 (GLOBE NEWSWIRE) — Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin-3, today announced it will partic
<p>Nuant, a leader in Digital Asset Portfolio Management Systems, is pleased to announce its collaboration with MSCI Inc., a leading provider of mission-critical decision support tools and servi
Leave a Comment